Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Next-generation sequencing in understanding complex neurological disease.
Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis.
Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
Similar genetics of adult and pediatric MS: Age is just a number.
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
The essential role of t cells in multiple sclerosis: A reappraisal.
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
The top clinical trial opportunities in therapeutic apheresis and neurology.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Transglutaminase 2 and neuroinflammation.
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.
Role of STIM-dependent Ca(2+) Influx in Regulatory B Cells.
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic.

Pages